Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
   J01 ANTIBACTERIALS FOR SYSTEMIC USE
     J01A TETRACYCLINES
     J01B AMPHENICOLS
     J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS
     J01D OTHER BETA-LACTAM ANTIBACTERIALS
     J01E SULFONAMIDES AND TRIMETHOPRIM
     J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
     J01G AMINOGLYCOSIDE ANTIBACTERIALS [DG:DG01447]
     J01M QUINOLONE ANTIBACTERIALS [DG:DG01550]
       J01MA Fluoroquinolones [DG:DG01549]
         J01MA01 Ofloxacin [DG:DG00616]
         J01MA02 Ciprofloxacin [DG:DG00617]
         J01MA03 Pefloxacin [DG:DG00618]
         J01MA04 Enoxacin [DG:DG00619]
           D00310  Enoxacin (USAN/INN)
           D05461  Enoxacin hydrate (JP18)
         J01MA05 Temafloxacin
         J01MA06 Norfloxacin [DG:DG00620]
         J01MA07 Lomefloxacin [DG:DG00621]
         J01MA08 Fleroxacin
         J01MA09 Sparfloxacin
         J01MA10 Rufloxacin [DG:DG00622]
         J01MA11 Grepafloxacin [DG:DG00623]
         J01MA12 Levofloxacin [DG:DG00624]
         J01MA13 Trovafloxacin [DG:DG00625]
         J01MA14 Moxifloxacin [DG:DG00626]
         J01MA15 Gemifloxacin [DG:DG00627]
         J01MA16 Gatifloxacin [DG:DG00628]
         J01MA17 Prulifloxacin
         J01MA18 Pazufloxacin [DG:DG00629]
         J01MA19 Garenoxacin
         J01MA21 Sitafloxacin
         J01MA22 Tosufloxacin [DG:DG01217]
         J01MA23 Delafloxacin [DG:DG01215]
         J01MA24 Levonadifloxacin
         J01MA25 Lascufloxacin
       J01MB Other quinolones
     J01R COMBINATIONS OF ANTIBACTERIALS
     J01X OTHER ANTIBACTERIALS
   J02 ANTIMYCOTICS FOR SYSTEMIC USE
   J04 ANTIMYCOBACTERIALS
   J05 ANTIVIRALS FOR SYSTEMIC USE
   J06 IMMUNE SERA AND IMMUNOGLOBULINS
   J07 VACCINES
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: May 1, 2024
According to WHO's ATC 2024

» Japanese version